✦ LIBER ✦

Does a long-acting atypical antipsychotic offer a low risk of tardive dyskinesia in patients with schizophrenia?

✍ Scribed by G. Chouinard; R. Lasser; C. Bossie; Y. Zhu; G. Gharabawi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH6 Effectiveness of Long-Acting Iinjec

✍ L. Hargarter; J. Fleischmann; J. Diels; J. Rabinowitz; M. Hemels; M. Gaudig; S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A PROSPECTIVE STUDY OF INSIGHT AND ITS R

✍ Maju Koola 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P.2.013 Safety and efficacy of long-acti

✍ M. Cetin; S. Ebrinc; C. Basoglu; U.B. Semiz; H. Gunay; M.S. Iyisoy; B.M. Ergun; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Typical and atypical antipsychotics diff

✍ Marc De Hert; Vincent Schreurs; Kim Sweers; Dominique Van Eyck; Linda Hanssens; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 169 KB

TYPICAL AND ATYPICAL ANTIPSYCHOTICS DIFF

✍ Marc De Hert; Ruud van Winkel; Vincent Schreurs; Linda Hanssens; Martien Wampers 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

PMH55 CANADIAN COST-EFFECTIVENESS ANALYS

✍ Lam, A; Heeg, B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB